Compare Nutanix Inc (NTNX) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutanix Inc vs Tilray Brands Inc — how do they compare? Nutanix Inc trades at $74.63 (market cap $19.78B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Nutanix Inc is far larger — about 37.3× Tilray Brands Inc's market cap, and Nutanix Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nutanix Inc for 17 Days and Tilray Brands Inc for 31 Days on average.
| NTNX | TLRY | |
|---|---|---|
Market Cap | $19.78B | $530.54M |
Volume | 1,717,619 | 9,099,075 |
Sector | Technology | Health |
52-Week High | $74.63 | $17.20 |
52-Week Low | $34.41 | $3.54 |
Typical Hold Time | 17 Days | 31 Days |
Enterprise Value | $18.94B | $684.46M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nutanix (NTNX) trades at $73.08, down 0.46% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with consistent earnings beats, including Q2 2026 EPS of $0.60 beating expectations of $0.49, and impressive net income margin expansion to 52.81% in 2026. Recent Gartner Magic Quadrant recognitions highlight competitive strength in server virtualization and container management.
The outlook remains positive with analyst consensus targeting $76.11, though elevated valuation ratios and negative ROE present risks. Key catalysts include external storage growth and AI initiatives, while supply chain pressures and competitive threats warrant monitoring. The stock's proximity to resistance at $74 suggests potential near-term consolidation before further upside.
TLRY trades at $3.59, down 3.36% on the day and near 52-week lows, with a bearish technical signal. The company reported revenue of $821.31M for 2025 but posted a net loss of -$2.19B, missing earnings expectations for four consecutive quarters. While analyst consensus shows 70% hold ratings, the stock faces significant profitability challenges with negative margins and cash flow concerns despite some revenue growth projections.
The outlook remains challenging with persistent losses and negative cash flow, though the stock trades at discounted valuation multiples. Key risks include ongoing profitability struggles and cannabis regulatory uncertainty. Potential catalysts include upcoming Q1 2027 earnings on October 8, 2026, and potential marijuana reform developments that could benefit the company's positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
